NO904569D0 - Benzimidazolderivater og fremgangsmaate for deres fremstilling. - Google Patents

Benzimidazolderivater og fremgangsmaate for deres fremstilling.

Info

Publication number: NO904569D0
Authority: NO; Norway
Prior art keywords: group; procedures; preparation; derivatives; benzimidazold
Prior art date: 1989-10-24

Application number

NO904569A

Other languages

English (en)

Other versions

NO904569L (no

NO177304C (no

NO177304B (no

Inventor

Takehiko Naka

Kohei Nishikawa

Original Assignee

Takeda Chemical Industries Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1989-10-24

Filing date

1990-10-23

Publication date

1990-10-23

1990-10-23 Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd

1990-10-23 Publication of NO904569D0 publication Critical patent/NO904569D0/no

1991-04-25 Publication of NO904569L publication Critical patent/NO904569L/no

1995-05-15 Publication of NO177304B publication Critical patent/NO177304B/no

1995-08-23 Publication of NO177304C publication Critical patent/NO177304C/no

Links

238000000034 method Methods 0.000 title 1
125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 2
102000005862 Angiotensin II Human genes 0.000 abstract 1
101800000733 Angiotensin-2 Proteins 0.000 abstract 1
208000024172 Cardiovascular disease Diseases 0.000 abstract 1
CZGUSIXMZVURDU-JZXHSEFVSA-N Ile(5)-angiotensin II Chemical compound C([C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC=1C=CC=CC=1)C([O-])=O)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(N)=[NH2+])NC(=O)[C@@H]([NH3+])CC([O-])=O)C(C)C)C1=CC=C(O)C=C1 CZGUSIXMZVURDU-JZXHSEFVSA-N 0.000 abstract 1
229950006323 angiotensin ii Drugs 0.000 abstract 1
150000001450 anions Chemical class 0.000 abstract 1
230000003042 antagnostic effect Effects 0.000 abstract 1
239000003814 drug Substances 0.000 abstract 1
150000002460 imidazoles Chemical class 0.000 abstract 1
229940079865 intestinal antiinfectives imidazole derivative Drugs 0.000 abstract 1
125000000843 phenylene group Chemical group C1(=C(C=CC=C1)*)* 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1
125000006850 spacer group Chemical group 0.000 abstract 1
125000001424 substituent group Chemical group 0.000 abstract 1
125000000547 substituted alkyl group Chemical group 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
- C07D235/08—Radicals containing only hydrogen and carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
- C07D235/12—Radicals substituted by oxygen atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/645—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
- C07F9/6503—Five-membered rings
- C07F9/6506—Five-membered rings having the nitrogen atoms in positions 1 and 3
- C07F9/65068—Five-membered rings having the nitrogen atoms in positions 1 and 3 condensed with carbocyclic rings or carbocyclic ring systems

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
General Chemical & Material Sciences (AREA)
Public Health (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Urology & Nephrology (AREA)
Biochemistry (AREA)
Molecular Biology (AREA)
Vascular Medicine (AREA)
Reproductive Health (AREA)
Endocrinology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Polyesters Or Polycarbonates (AREA)
Steroid Compounds (AREA)

NO904569A 1989-10-24 1990-10-23 Analogifremgangsmåte for fremstilling av terapeutisk aktive benzimidazolderivater NO177304C (no)

Applications Claiming Priority (6)

Application Number	Priority Date	Filing Date	Title
JP27738589		1989-10-24
JP32897489		1989-12-18
JP514790		1990-01-11
JP9167590		1990-04-05
JP9732490		1990-04-11
JP11314590		1990-04-27

Publications (4)

Publication Number	Publication Date
NO904569D0 true NO904569D0 (no)	1990-10-23
NO904569L NO904569L (no)	1991-04-25
NO177304B NO177304B (no)	1995-05-15
NO177304C NO177304C (no)	1995-08-23

Family

ID=27547894

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO904569A NO177304C (no)	1989-10-24	1990-10-23	Analogifremgangsmåte for fremstilling av terapeutisk aktive benzimidazolderivater

Country Status (14)

Country	Link
US (1)	US5128356A (no)
EP (1)	EP0425921B1 (no)
JP (1)	JP3099241B2 (no)
AT (1)	ATE126219T1 (no)
AU (1)	AU649418B2 (no)
CA (1)	CA2028302C (no)
DE (1)	DE69021502T2 (no)
FI (1)	FI102068B (no)
HU (1)	HUT55384A (no)
IE (1)	IE67956B1 (no)
IL (1)	IL95975A (no)
NO (1)	NO177304C (no)
NZ (1)	NZ235762A (no)
PT (2)	PT95655B (no)

Families Citing this family (79)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE3928177A1 (de) *	1989-04-08	1991-02-28	Thomae Gmbh Dr K	Benzimidazole, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
GB8911854D0 (en) *	1989-05-23	1989-07-12	Ici Plc	Heterocyclic compounds
IE70593B1 (en) *	1989-09-29	1996-12-11	Eisai Co Ltd	Biphenylmethane derivative the use of it and pharmacological compositions containing same
DE122007000050I1 (de) *	1990-02-19	2007-11-08	Novartis Ag	Acylverbindungen
FR2670489B1 (fr) *	1990-12-18	1994-10-14	Roussel Uclaf	Nouveaux derives de benzimidazole, leur procede de preparation, les nouveaux intermediaires obtenus, leur application a titre de medicaments et les compositions pharmaceutiques les renfermant.
FR2674523A1 (fr) *	1991-03-28	1992-10-02	Roussel Uclaf	Nouveaux derives de benzimidazole, leur procede de preparation, les nouveaux intermediaires obtenus, leur application a titre de medicaments et les compositions pharmaceutiques les renfermant.
ES2121773T3 (es) *	1990-06-08	1998-12-16	Hoechst Marion Roussel Inc	Derivados de bencimidazol, su procedimiento de preparacion, productos intermedios, su aplicacion como medicamentos y composiciones farmaceuticas que los contienen.
RU1836357C (ru) *	1990-07-23	1993-08-23	Др.Карл Томэ ГмбХ	Производные бензимидазола, их изомеры, смеси изомеров, гидраты или их физиологически переносимые соли, обладающие антагонистическими в отношении ангиотензина свойствами
DE4036706A1 (de) *	1990-11-17	1992-05-21	Hoechst Ag	Verfahren zur behandlung der cardialen sowie der vasculaeren hypertrophie und hyperplasie
AU657498B2 (en) *	1990-12-14	1995-03-16	Novartis Ag	Biphenylyl compounds
TW274551B (no) *	1991-04-16	1996-04-21	Takeda Pharm Industry Co Ltd
AU654349B2 (en) *	1991-05-16	1994-11-03	Glaxo Group Limited	Benzofuran derivatives
IL102183A (en) *	1991-06-27	1999-11-30	Takeda Chemical Industries Ltd	Biphenyl substituted heterocyclic compounds their production and pharmaceutical compositions comprising them
TW300219B (no) *	1991-09-14	1997-03-11	Hoechst Ag
US5283242A (en) *	1991-10-24	1994-02-01	American Home Products Corporation	Substituted benzimidazoles and quinazolines as antihypertensives
TW284688B (no) *	1991-11-20	1996-09-01	Takeda Pharm Industry Co Ltd
JP2682353B2 (ja) *	1991-11-20	1997-11-26	武田薬品工業株式会社	経口用医薬組成物およびその製造法
US5378701A (en) *	1991-12-27	1995-01-03	Kyowa Hakko Kogyo	Tricyclic compounds
DE69230721T2 (de) *	1991-12-27	2000-08-31	Kyowa Hakko Kogyo Co., Ltd.	Tricyclische Verbindungen als Angiotensin-II-Antagonisten
WO1993017682A1 (en) *	1992-03-04	1993-09-16	Abbott Laboratories	Angiotensin ii receptor antagonists
US5605919A (en) *	1993-02-26	1997-02-25	Takeda Chemical Industries, Ltd.	Treatment for viral diseases
CA2115985A1 (en) *	1993-02-25	1994-08-26	Kohei Nishikawa	Vascular hypertrophy suppressor
JP2003306432A (ja) *	1993-04-22	2003-10-28	Takeda Chem Ind Ltd	腎疾患の予防または治療剤
JP3810020B2 (ja)	1993-04-22	2006-08-16	武田薬品工業株式会社	腎疾患の予防または治療剤
US5721263A (en) *	1993-06-07	1998-02-24	Takeda Chemical Industries, Ltd.	Pharmaceutical composition for angiotensin II-mediated diseases
CA2125251C (en)	1993-06-07	2005-04-26	Yoshiyuki Inada	A pharmaceutical composition for angiotensin ii-mediated diseases
CZ154994A3 (en) *	1993-07-02	1995-09-13	Senju Pharma Co	Visual hypotensive agent
ZA945190B (en) *	1993-07-30	1995-02-24	Kotobuki Seiyaku Co Ltd	Carboxymethylidenecycloheptimidazole derivatives method or manufacturing the same and therapeutic agents containing these compounds
AU679616B2 (en) *	1994-04-19	1997-07-03	Tanabe Seiyaku Co., Ltd.	Imidazopyridine derivatives and process for preparing the same
US5753672A (en) *	1994-04-19	1998-05-19	Tanabe Seiyaku Co., Ltd.	Imidazopyridine derivatives and process for preparing the same
CA2150610C (en) *	1994-06-01	1999-08-17	Mikiro Yanaka	Benzene derivatives and pharmaceutical composition
AU677702B2 (en) *	1994-10-13	1997-05-01	Takeda Pharmaceutical Company Limited	A prophylactic or therapeutic drug for renal diseases
TR199800127T1 (xx) *	1995-08-02	1998-04-21	Newcastle University Ventures Limited	Benzimidazol bile�ikleri.
JP3166065B2 (ja) *	1996-02-08	2001-05-14	東京エレクトロン株式会社	処理装置及び処理方法
US6177587B1 (en) *	1997-05-26	2001-01-23	Takeda Chemical Industries, Ltd.	Production method of aminobenzene compound
ID25640A (id)	1998-03-04	2000-10-19	Takeda Chemical Industries Ltd	Preparat pelepasan terus menerus untuk antagonistik aii, produksi dan penggunaannya
DE60037192T2 (de) *	1999-07-21	2008-05-15	Takeda Pharmaceutical Co. Ltd.	Mittel zur verbesserung der erkrankungen nach zerebralen durchblutungsstörungen sowie zur verhinderung deren fortschreitens
SE9903028D0 (sv)	1999-08-27	1999-08-27	Astra Ab	New use
TWI265925B (en)	1999-10-11	2006-11-11	Pfizer	Pyrazolo[4,3-d]pyrimidin-7-ones useful in inhibiting type 5 cyclic guanosine 3',5'-monophosphate phosphodiesterases(cGMP PDE5), process and intermediates for their preparation, their uses and composition comprising them
EP1346722B1 (en)	2000-12-01	2008-12-10	Takeda Pharmaceutical Company Limited	Method for producing preparation containing bioactive substance
US7812044B2 (en)	2001-11-13	2010-10-12	Takeda Pharmaceutical Company Limited	Anticancer agents
WO2003077914A1 (en)	2002-03-13	2003-09-25	Array Biopharma, Inc	N3 alkylated benzimidazole derivatives as mek inhibitors
US7232828B2 (en) *	2002-08-10	2007-06-19	Bethesda Pharmaceuticals, Inc.	PPAR Ligands that do not cause fluid retention, edema or congestive heart failure
ES2284068T3 (es)	2003-10-16	2007-11-01	Teva Pharmaceutical Industries Limited	Preparacion de candesartan cilexetilo.
US7692023B2 (en)	2004-02-11	2010-04-06	Teva Pharmaceutical Industries Ltd.	Candesartan cilexetil polymorphs
CN1953973A (zh) *	2004-05-05	2007-04-25	特瓦制药工业有限公司	高纯度坎地沙坦酯的制备
DE102004060699A1 (de) *	2004-12-16	2006-06-22	Ratiopharm Gmbh	Verfahren zur Herstellung von Candesartan
EP1863801B1 (en) *	2005-03-30	2010-09-29	Takeda Pharmaceutical Company Limited	Benzimidazole derivative and use thereof
EP1764365A1 (en) *	2005-09-20	2007-03-21	KRKA, D.D., Novo Mesto	A process for the preparation of sartan derivates and intermediates useful in such process
EA016728B1 (ru)	2006-08-10	2012-07-30	Такеда Фармасьютикал Компани Лимитед	Фармацевтическая композиция
WO2008142576A2 (en) *	2007-05-24	2008-11-27	Eldrug S.A.	1,(3,)5-substituted imidazoles, their use in the treatment of hypertension and methods for their preparation
EP2170930B3 (en)	2007-06-04	2013-10-02	Synergy Pharmaceuticals Inc.	Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
US8969514B2 (en)	2007-06-04	2015-03-03	Synergy Pharmaceuticals, Inc.	Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
EP2291076A4 (en) *	2008-05-15	2012-03-21	Merck Sharp & Dohme	Angiotensin-II Receptor Antagonists
JP2011522828A (ja)	2008-06-04	2011-08-04	シナジーファーマシューティカルズインコーポレイテッド	胃腸障害、炎症、癌、およびその他の障害の治療のために有用なグアニル酸シクラーゼのアゴニスト
EP2321341B1 (en)	2008-07-16	2017-02-22	Synergy Pharmaceuticals Inc.	Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders
WO2010067912A1 (en) *	2008-12-12	2010-06-17	Pharmacostech Co., Ltd.	Methods for preparing biphenyl benzoic acid derivatives
US9616097B2 (en)	2010-09-15	2017-04-11	Synergy Pharmaceuticals, Inc.	Formulations of guanylate cyclase C agonists and methods of use
NZ608069A (en)	2010-10-06	2014-06-27	Glaxosmithkline Llc	Benzimidazole derivatives as pi3 kinase inhibitors
BR112014030940B1 (pt)	2012-06-11	2022-09-06	UCB Biopharma SRL	Benzimidazóis que modulam tnf-alfa e composição farmacêutica compreendendo os mesmos
CA2905435A1 (en)	2013-03-15	2014-09-25	Synergy Pharmaceuticals Inc.	Compositions useful for the treatment of gastrointestinal disorders
US9708367B2 (en)	2013-03-15	2017-07-18	Synergy Pharmaceuticals, Inc.	Agonists of guanylate cyclase and their uses
AU2014247941C1 (en)	2013-04-04	2019-10-31	University Of Maryland, Baltimore	Nonsteroidal and steroidal compounds with potent androgen receptor down-regulation and anti prostate cancer activity
RS65632B1 (sr)	2013-06-05	2024-07-31	Bausch Health Ireland Ltd	Ultra-prečišćeni agonisti guanilat-ciklaze c, postupak njihove pripreme i upotrebe
WO2016032537A1 (en)	2014-08-30	2016-03-03	Innovative Building Technologies, Llc	A prefabricated wall panel for utility installation
US10260250B2 (en)	2014-08-30	2019-04-16	Innovative Building Technologies, Llc	Diaphragm to lateral support coupling in a structure
CZ2015687A3 (cs)	2015-10-02	2017-04-12	Zentiva, K.S.	Farmaceutická kompozice obsahující kombinaci kandesartanu, amlodipinu a hydrochlorthiazidu
US10508442B2 (en)	2016-03-07	2019-12-17	Innovative Building Technologies, Llc	Floor and ceiling panel for slab-free floor system of a building
MX2018010276A (es)	2016-03-07	2019-02-20	Innovative Building Tech Llc	Panel de pared pre-ensamblado para instalacion de servicio.
WO2017156011A1 (en)	2016-03-07	2017-09-14	Innovative Building Technologies, Llc	Prefabricated demising wall with external conduit engagement features
MX2018010275A (es)	2016-03-07	2019-02-11	Innovative Building Tech Llc	Ensambles de impermeabilizacion y paneles de pared prefabricados que incluyen los mismos.
CN110612289B (zh) *	2017-03-15	2023-06-30	住友制药株式会社	氘代的苯并咪唑化合物和其医药用途
US10724228B2 (en)	2017-05-12	2020-07-28	Innovative Building Technologies, Llc	Building assemblies and methods for constructing a building using pre-assembled floor-ceiling panels and walls
US10487493B2 (en)	2017-05-12	2019-11-26	Innovative Building Technologies, Llc	Building design and construction using prefabricated components
US11098475B2 (en)	2017-05-12	2021-08-24	Innovative Building Technologies, Llc	Building system with a diaphragm provided by pre-fabricated floor panels
US10323428B2 (en)	2017-05-12	2019-06-18	Innovative Building Technologies, Llc	Sequence for constructing a building from prefabricated components
JP7038004B2 (ja)	2018-05-24	2022-03-17	本田技研工業株式会社	光学部品の洗浄方法及び洗浄装置
JP7098838B2 (ja)	2018-11-14	2022-07-11	イノベイティブビルディングテクノロジーズ，エルエルシー	モジュール式階段室およびエレベータシャフトシステムならびに方法
CN120887708B (zh) *	2025-09-30	2025-12-23	河北鼎瓷电子科技股份有限公司	高热导多层陶瓷基板及其制备方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS5671074A (en) *	1979-11-12	1981-06-13	Takeda Chem Ind Ltd	1,2-disubstituted-4-halogenoimidazole-5-acetic acid derivative
JPS5671073A (en) *	1979-11-12	1981-06-13	Takeda Chem Ind Ltd	Imidazole derivative
US4612323A (en) *	1983-06-27	1986-09-16	Sumitomo Chemical Company, Limited	Insecticidal and acaricidal derivatives of 1-benzylbenzimidazole
JPS61151176A (ja) *	1984-12-24	1986-07-09	Sumitomo Chem Co Ltd	ベンズイミダゾール誘導体およびそれを有効成分とする殺虫、殺ダニ剤
US4812462A (en) *	1986-04-01	1989-03-14	Warner-Lambert Company	4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridine-6-carboxylic acid analogs having antihypertensive activity
CA1334092C (en) *	1986-07-11	1995-01-24	David John Carini	Angiotensin ii receptor blocking imidazoles
US4820843A (en) *	1987-05-22	1989-04-11	E. I. Du Pont De Nemours And Company	Tetrazole intermediates to antihypertensive compounds
US5015651A (en) *	1988-01-07	1991-05-14	E. I. Du Pont De Nemours And Company	Treatment of hypertension with 1,2,4-angiotensin II antagonists
US4880804A (en) *	1988-01-07	1989-11-14	E. I. Du Pont De Nemours And Company	Angiotensin II receptor blocking benzimidazoles
JPH0273071A (ja) *	1988-09-09	1990-03-13	Sumitomo Chem Co Ltd	ベンズイミダゾール誘導体、その製造法およびそれを有効成分とする殺虫、殺ダニ剤
DE3928177A1 (de) *	1989-04-08	1991-02-28	Thomae Gmbh Dr K	Benzimidazole, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
EP0400835A1 (en) *	1989-05-15	1990-12-05	Merck & Co. Inc.	Substituted benzimidazoles as angiotensin II antagonists
GB8911854D0 (en) *	1989-05-23	1989-07-12	Ici Plc	Heterocyclic compounds
IE70593B1 (en) *	1989-09-29	1996-12-11	Eisai Co Ltd	Biphenylmethane derivative the use of it and pharmacological compositions containing same

1990
- 1990-10-12 IL IL95975A patent/IL95975A/xx not_active IP Right Cessation
- 1990-10-15 AU AU64612/90A patent/AU649418B2/en not_active Ceased
- 1990-10-19 EP EP90120054A patent/EP0425921B1/en not_active Expired - Lifetime
- 1990-10-19 AT AT90120054T patent/ATE126219T1/de not_active IP Right Cessation
- 1990-10-19 US US07/599,894 patent/US5128356A/en not_active Expired - Fee Related
- 1990-10-19 NZ NZ235762A patent/NZ235762A/en unknown
- 1990-10-19 DE DE69021502T patent/DE69021502T2/de not_active Expired - Fee Related
- 1990-10-23 PT PT95655A patent/PT95655B/pt not_active IP Right Cessation
- 1990-10-23 FI FI905215A patent/FI102068B/fi not_active IP Right Cessation
- 1990-10-23 CA CA002028302A patent/CA2028302C/en not_active Expired - Fee Related
- 1990-10-23 JP JP02286299A patent/JP3099241B2/ja not_active Expired - Fee Related
- 1990-10-23 IE IE380390A patent/IE67956B1/en not_active IP Right Cessation
- 1990-10-23 NO NO904569A patent/NO177304C/no not_active IP Right Cessation
- 1990-10-24 HU HU906539A patent/HUT55384A/hu unknown
1996
- 1996-05-24 PT PT101875A patent/PT101875B/pt not_active IP Right Cessation

Also Published As

Publication number	Publication date
PT101875A (pt)	1997-12-31
HUT55384A (en)	1991-05-28
US5128356A (en)	1992-07-07
NZ235762A (en)	1992-04-28
EP0425921A1 (en)	1991-05-08
IL95975A (en)	1997-06-10
FI102068B1 (fi)	1998-10-15
CA2028302A1 (en)	1991-04-25
IE67956B1 (en)	1996-05-15
FI905215A0 (fi)	1990-10-23
JPH049373A (ja)	1992-01-14
AU6461290A (en)	1991-05-02
PT101875B (pt)	1999-04-30
JP3099241B2 (ja)	2000-10-16
DE69021502D1 (de)	1995-09-14
NO904569L (no)	1991-04-25
IL95975A0 (en)	1991-07-18
PT95655B (pt)	1996-09-30
IE903803A1 (en)	1991-04-24
DE69021502T2 (de)	1996-01-11
NO177304C (no)	1995-08-23
HU906539D0 (en)	1991-04-29
EP0425921B1 (en)	1995-08-09
CA2028302C (en)	2002-01-15
PT95655A (pt)	1991-09-13
AU649418B2 (en)	1994-05-26
FI102068B (fi)	1998-10-15
NO177304B (no)	1995-05-15
ATE126219T1 (de)	1995-08-15

Publication	Publication Date	Title
NO904569D0 (no)	1990-10-23	Benzimidazolderivater og fremgangsmaate for deres fremstilling.
DK0629609T3 (da)	1996-12-23	Fremgangsmåde til fremstilling af alkoxyiminoacetamidderivater og et mellemprodukt dertil
EP0256503A3 (en)	1989-07-19	Pyridinecarboxamide derivatives and their use as fungicide
NO893453D0 (no)	1989-08-29	Antibakterielle spiro-forbindelser og fremgangsmaate for deres fremstilling.
AU5117890A (en)	1990-09-13	Trifluromethylphenylazolylmethyloxiranes, the preparation thereof and the use thereof as crop protection agents
ATE93232T1 (de)	1993-09-15	Bis(methylendioxy)biphenyl-verbindungen.
ES2043807T3 (es)	1994-01-01	Compuestos anticancer.
FI852223L (fi)	1985-12-08	Saosom fungicider anvaenda triazoler.
NZ221699A (en)	1990-03-27	Pyridazinone derivatives; pharmaceutical compositions and intermediates
DK147588D0 (da)	1988-03-17	Benzoxazinderivat samt fremgangsmaade til fremstilling deraf
ATE69605T1 (de)	1991-12-15	Azolylpropenyl- und azolylmethyloxiran-derivate und diese enthaltende fungizide.
DK23089D0 (da)	1989-01-19	Thioformamidderivater og deres anvendelse
FR2354326A1 (fr)	1978-01-06	Nouveaux 3-(alkyl oxygene)-1,9-dihydroxy (ou 1-hydroxy-9-ceto)-dibenzo (b,d) pyrannes a activite analgesique
ATE105565T1 (de)	1994-05-15	Pradimicinderivate.
ES2024332A6 (es)	1992-02-16	Procedimiento para la obtencion de nuevas sulfonamidas.
DK0391673T3 (da)	1993-06-28	Fremstilling af glutarsyrederivater
ES2012695A6 (es)	1990-04-01	Un procedimiento para la preparacion de 4-(6'-metoxi -2'- naftil)-but-3-en -2-ona.
DE3769383D1 (de)	1991-05-23	Herbizide cyclohexan-1,3-dion-derivate.
ES8500937A1 (es)	1984-11-01	Un procedimiento de preparacion de nuevos benzopirano-(2,3-d)-v-triazoles.
MY104164A (en)	1994-02-28	Heterocyclic compounds.
EP0005980A3 (en)	1980-01-09	Derivatives of substituted n-alkyl imidazoles, their preparation and pharmaceutical use

Legal Events

Date	Code	Title	Description
2003-06-02	MM1K	Lapsed by not paying the annual fees	Free format text: LAPSED IN APRIL 2003